Total Funding
53
37
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
182912
ERYtech Pharma is a biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.
- Francoise Horand: Director of Research and Development Operations
- Jean Sebastien Cleiftie: Chief Business Officer
About the Company
ERYtech Pharma specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.
